Loading…
Vestis Corporation
🏹 Trader: 📈 Stage 2 | BRS 64 Forming View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$1.7B
Market Cap
94.4
P/E
1.69
PEG
2.6%
ROCE
-4.5%
ROE
1.57
D/E
2.4%
OPM
-22.7%
% from 52W High
92
α RS
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for VSTS including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Vestis Corporation provides uniform rentals and workplace supplies in the United States and Canada.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding VSTS
View All Superinvestors →
Manager Shares Value % of Fund Period
Jim Simons Renaissance Technologies LLC 509.1K $4.0M 0.01% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific ↑ Improving 3 quarters Full tone analysis in Intelligence →
📊 MIXED Vestis Q2 adjusted EBITDA $75M, +19% YoY; first growth in over 2 years.
Revenue & Profitability
Revenue was $659 million, down 0.9% year-over-year. Net income was $2.6 million compared to a net loss of $27.8 million in the prior year. Adjusted EBITDA was $74.5 million (11.3% margin), up from $47.6 million (7.2%) in the prior year, or $62.6 million (9.4%) excluding a $15 million bad debt adjustment.
Outlook
Management expects to return to top-line growth in the fourth quarter of fiscal 2026. They are raising full-year guidance for adjusted EBITDA to $295-$325 million and free cash flow to $120-$150 million. The company sees opportunities from market consolidation, particularly the proposed merger between Synthes and UniFirst, and is receiving inbound calls from customers and employees of those companies.
Growth Drivers
Key growth levers include the Market Development Representative (MDR) program, strategic pricing, and product mix shift toward higher-margin uniforms and away from low-margin linen. New sales productivity improved 50% year-over-year. The company is also focused on deeper penetration in national accounts and field sales, with an emphasis on profitability over volume.
Balance Sheet & CapEx
In Q2, capital investments were $24.7 million, including $12.7 million in cash investments and $12 million in new finance leases for the delivery fleet. Full-year cash capital expenditure guidance is $60-$70 million. The company is also actively marketing 11 non-operating properties with an estimated value of approximately $15 million.
Margins
Adjusted EBITDA margin improved to 11.3% from 7.2% (or 9.4% on an adjusted basis) year-over-year. Operating leverage improved by $0.02 per pound, driven by a $0.02 reduction in cost per pound, with revenue per pound flat. Sequential EBITDA growth of about 5% in Q3 and 5%-10% in Q4 is expected, leading to an increased midpoint of $310 million for full-year adjusted EBITDA.
Key Risks
Risks include the regulatory process for the Synthes-UniFirst merger (FTC), potential disruption from market consolidation, and the execution of the business transformation. The company is intentionally exiting low-margin volume, which is causing a temporary decline in pounds processed. Non-regrettable churn is expected to continue as pricing floors are enforced.
Generated by AI · Q2 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q3 2026 Q3 2026 2026-08-11
Adjusted EBITDA grew 23% year-over-year with margin expansion, driven by disciplined pricing, improved product mix, and operational excellence. Free cash flow guidance was raised, and transformation initiatives are delivering cost savings and improved revenue quality.
Q2 2026 Q2 2026 2026-05-12
Second quarter saw adjusted EBITDA rise 19% year-over-year to $74.5 million, with improved operating leverage and cost control. Guidance for full-year adjusted EBITDA and free cash flow was raised, and a return to top-line growth is expected in Q4 2026.
Q1 2026 Q1 2026 2026-02-10
Q1 2026 saw sequential EBITDA improvement and strong operational gains, despite a 3% revenue decline driven by product mix shifts. Guidance for 2026 is reaffirmed, with ongoing transformation expected to drive cost and revenue per pound improvements.
Q4 2025 Q4 2025 2025-12-02
Q4 2025 normalized revenue declined 3.5% year-over-year, with adjusted EBITDA at $65M and gross margin down 366 bps. A multi-year transformation plan aims for $75M in cost savings by 2026, with 2026 revenue expected flat to down 2% and adjusted EBITDA guidance of $285M–$315M.
Q3 2025 Q3 2025 2025-08-06
Q3 revenue declined 3.5% year-over-year due to higher churn and lower pricing on new contracts, with gross margin and adjusted EBITDA also down. Leadership is focused on value-based pricing, cost efficiency, and operational improvements, with near-term trends expected to persist.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.